Follow us on

Our blog

Jul 27, 2022

Ultrasound-guided percutaneous carpal tunnel release: A New Recent Systematic erview

by Dr. Walter I. Sussman

Carpal tunnel syndrome is the most common peripheral entrapment, and clinical symptoms consist of numbness, paresthesia, pain and weakness (Atroshi et al, 1999). Traditional carpal tunnel syndrome is performed using an open, endoscopic and mini-open approach. A percutaneous approach using ultrasound guidance was first described in 2005 by Rowe et al. in a cadaveric study. This approach relies on using an ultrasound probe to visualize the at-risk structures, including the median nerve and adjacent arteries.

In a recent systematic review evaluating the clinical efficacy and safety of ultrasound guided carpal tunnel release, Chou et al screened 87 studies and found 20 studies with a total of 1,772 cases of percutaneous ultrasound guided carpal tunnel releases.

The authors found that these early studies suggest that percutaneous carpal tunnel release was effective. No permanent nerve or vascular complications were reported. The return to work was significantly shorter on average that the mini-open carpal tunnel release.

References:

  1. Atroshi I, Gummesson C, Johnsson R, Ornstein E, Ranstam JRI. Prevalence of carpal tunnel syndrome in a general population. JAMA. 1999;282(2):153-158.
  2. Chou RC, Robinson DM, Homer S. Ultrasound-guided percutaneous carpal tunnel release: A systematic review. PM R. 2022 Mar 7.
  3. Rowe NM, Michaels VJ, Soltanian H, et al. Sonographically guided percutaneous carpal tunnel release: an anatomic and cadaveric study. Ann Plast Surg. 2005;55(1):52-56.

More Articles

Jun 17, 2026

Distinguishing SIRVA from Pre-Existing Degenerative Shoulder Disease: What Patients and Physicians Need to Know

Learn how to differentiate SIRVA from rotator cuff tears, arthritis, and other degenerative shoulder conditions after vaccination. Expert review.

Read More
Jun 14, 2026

Amniotic Stem Cell Injections: What Patients Need to Know About FDA Regulations, Cell Viability, and Safety Concerns

Many amniotic fluid and birth-tissue products are marketed as "stem cell injections" for arthritis and orthopedic injuries. Learn how these products are made, why the FDA considers many of them unapproved biologic

Read More